Literature DB >> 2153599

Influence of atrial natriuretic peptide on mammalian large intestine.

K J Moriarty1, N B Higgs, M Lees, A Tonge, T D Wardle, G Warhurst.   

Abstract

Atrial natriuretic peptide is distributed in a number of organs including the large intestine. Atrial natriuretic peptide has potent diuretic and natriuretic properties and appears to play a central role in fluid and electrolyte homeostasis by an action on the kidney. We examined the influence of atrial natriuretic peptide on mammalian colon because this organ is also intimately involved in homeostasis. Segments of the distal colons of male Sprague-Dawley rats were stripped of muscle layers and mounted in flux chambers. Atrial natriuretic peptide, when added to the serosal side of the mucosa, in concentrations ranging from 10(-8)-10(-5) M, caused a rapid, concentration-dependent increase in short-circuit current, transmucosal electrical potential difference, and conductance. The response to atrial natriuretic peptide was inhibited by (a) chloride-free solution on the serosal surface; (b) pretreatment of the tissues with the chloride channel blocker, diphenylamine-2-carboxylate (10(-3) M mucosally); (c) pretreatment with d,l-verapamil (10(-4) M mucosally and serosally); (d) calcium-free solution on the serosal surface; (e) pretreatment with tetrodotoxin (10(-7) M to serosal surface); and (f) pretreatment with atropine (10(-5) M serosally). However, the response to atrial natriuretic peptide was not influenced by pretreatment with amiloride (10(-4) M to mucosal and serosal surfaces) or piroxicam (10(-5) M serosally). Atrial natriuretic peptide did not elicit an increase in short-circuit current and potential difference across T84 cells derived from a human colonic carcinoma cell line, suggesting that the response to atrial natriuretic peptide is not due to a direct effect on colonocytes. These findings suggest that atrial natriuretic peptide acts by a calcium-mediated secretory mechanism involving cholinergic nerves and is likely to be involved in the endogenous neurohumoral regulation of ion transport in the mammalian colon.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153599     DOI: 10.1016/0016-5085(90)90284-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  7 in total

Review 1.  Ultracytochemistry as a tool for the study of the cellular and subcellular localization of membrane-bound guanylate cyclase (GC) activity. Applicability to both receptor-activated and receptor-independent GC activity.

Authors:  Maria Grazia Rambotti; Antonio Spreca; Ileana Giambanco; Guglielmo Sorci; Rosario Donato
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

2.  Atrial natriuretic peptide inhibits mineralocorticoid receptor function in rat colonic surface cells.

Authors:  G Schulman; R Lindemeyer; A Barman; S Karnik; C P Bastl
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Inhibition of goby posterior intestinal NaCl absorption by natriuretic peptides and by cardiac extracts.

Authors:  C A Loretz
Journal:  J Comp Physiol B       Date:  1996       Impact factor: 2.200

4.  Discrepancies between effects of recombinant human growth hormone on absorption and secretion of water and electrolytes on the human jejunum compared to results reported on rat jejunum.

Authors:  C Högenauer; C A Santa Ana; J L Porter; J S Fordtran
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

5.  Action of ANG II and ANP on colon epithelial cells.

Authors:  Raif Musa-Aziz; Margarida Mello-Aires
Journal:  Pflugers Arch       Date:  2005-07-07       Impact factor: 3.657

Review 6.  Atrial natriuretic peptide in peripheral organs other than the heart.

Authors:  A M Vollmar
Journal:  Klin Wochenschr       Date:  1990-07-17

7.  Only pharmacological doses of atrial natriuretic peptide affect intestinal ion transport in non-volume expanded rats.

Authors:  R Lübcke; J Brunner; F A Hutcheson; G O Barbezat
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.